HLA-DP antigens in HIV-infected individuals
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
HLA-DP antigens in HIV-infected individuals. / Ødum, Niels; Georgsen, J; Fugger, L; Møller, J; Jakobsen, B K; Hofmann, B; Skinhøj, P; Klokker, M; Dickmeiss, E; Svejgaard, A.
I: Disease Markers, Bind 8, Nr. 3, 1991, s. 113-6.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - HLA-DP antigens in HIV-infected individuals
AU - Ødum, Niels
AU - Georgsen, J
AU - Fugger, L
AU - Møller, J
AU - Jakobsen, B K
AU - Hofmann, B
AU - Skinhøj, P
AU - Klokker, M
AU - Dickmeiss, E
AU - Svejgaard, A
N1 - Keywords: Acquired Immunodeficiency Syndrome; Disease Susceptibility; Genetic Markers; HIV Infections; HLA-DP Antigens; Humans; Lymphocyte Culture Test, Mixed; Male; Risk Factors
PY - 1991
Y1 - 1991
N2 - We studied the distribution of HLA-DP antigens in 74 HIV-infected Danish homosexual men and 188 ethnically matched healthy individuals, using the primed lymphocyte typing (PLT) technique. Forty of the patients developed AIDS within 3 years after diagnosis, whereas the remaining 34 were healthy or had only minor symptoms for 3 years or more (median observation time was 42 months). HLA-DPwl seemed to be decreased (relative risk = 0.3) in AIDS patients (5.0 per cent) when compared to patients with minor symptoms (14.7 per cent) and healthy controls (14.9 per cent). These differences were, however, not statistically significant. There were no other apparent deviations between patients (or subgroups of patients) and controls.
AB - We studied the distribution of HLA-DP antigens in 74 HIV-infected Danish homosexual men and 188 ethnically matched healthy individuals, using the primed lymphocyte typing (PLT) technique. Forty of the patients developed AIDS within 3 years after diagnosis, whereas the remaining 34 were healthy or had only minor symptoms for 3 years or more (median observation time was 42 months). HLA-DPwl seemed to be decreased (relative risk = 0.3) in AIDS patients (5.0 per cent) when compared to patients with minor symptoms (14.7 per cent) and healthy controls (14.9 per cent). These differences were, however, not statistically significant. There were no other apparent deviations between patients (or subgroups of patients) and controls.
M3 - Journal article
C2 - 2148714
VL - 8
SP - 113
EP - 116
JO - Disease Markers
JF - Disease Markers
SN - 0278-0240
IS - 3
ER -
ID: 10636600